Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer
Author(s) -
Koen M.A. Dreijerink,
Anna C. Groner,
Erica S.M. Vos,
Alba FontTello,
Lei Gu,
David Chi,
Jaime M. Reyes,
Jennifer Cook,
Elgene Lim,
Charles Y. Lin,
Wouter de Laat,
Prakash K. Rao,
Henry W. Long,
Myles Brown
Publication year - 2017
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2017.02.025
Subject(s) - men1 , carcinogenesis , foxa1 , cancer research , biology , enhancer , transcription factor , tumor suppressor gene , breast cancer , gata3 , promoter , gene , suppressor , cancer , gene expression , genetics , multiple endocrine neoplasia
While the multiple endocrine neoplasia type 1 (MEN1) gene functions as a tumor suppressor in a variety of cancer types, we explored its oncogenic role in breast tumorigenesis. The MEN1 gene product menin is involved in H3K4 trimethylation and co-activates transcription. We integrated ChIP-seq and RNA-seq data to identify menin target genes. Our analysis revealed that menin-dependent target gene promoters display looping to distal enhancers that are bound by menin, FOXA1 and GATA3. In this fashion, MEN1 co-regulates a proliferative breast cancer-specific gene expression program in ER + cells. In primary mammary cells, MEN1 exerts an anti-proliferative function by regulating a distinct expression signature. Our findings clarify the cell-type-specific functions of MEN1 and inform the development of menin-directed treatments for breast cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom